SlideShare ist ein Scribd-Unternehmen logo
1 von 24
Downloaden Sie, um offline zu lesen
Introduction
➢A secondary immune response is a response to an illness that has
occurred for the second time
➢It activates previously generated memory cells
➢Secondary immune response is different from the primary response,
both qualitatively and quantitatively
➢The log phase in secondary response is very short or negligible
➢Lag face is absent in secondary response
➢Raise of antibody concentration is about 100 to 1,000 fold higher than
the primary response resulting a short log phase
1° Immune Response
1. Following the first exposure to a
foreign antigen, a lag phase occurs in
which no antibody is produced, but
activated B cells are differentiating
into plasma cells. The lag phase can
be as short as 2-3 days, but often is
longer, sometimes as long as weeks
or months.
2. The amount of antibody produced is
usually relatively low.
3. Over time, antibody level declines to
the point where it may be
undetectable.
4. The first antibody produced is
manily IgM (although small amounts
of IgG are usually also produced).
2° Immune Response
1. If a second dose of the same antigen
is given days or even years later, an
accelerated 2° or anamnestic immune
response (IR) occurs. This lag phase
is usually very short (e.g. 3 or 4
days) due to the presence of memory
cells.
2. The amount of antibody produced
rises to a high level.
3. Antibody level tends to remain high
for longer.
4. The main type of antibody produced
is IgG (although small amounts of
IgM are sometimes produced).
Immunological Memory Is Sustained By Clones
Of Long Lived Memory T Cells And B Cells
➢After the level of pathogen-specific antibody made during a primary immune response
has declined, immune defences relaxed and the potential for that pathogen to re-
establish an infection increases
➢During a primary immune response, the clonal expansion of pathogen-specific T cells
and B cells gives rise both to short lived effector cells that work to stop the infection and
to long-lived memory T cells and memory B cells
➢In the secondary immune response, these memory cells are activated by antigen to
proliferate and differentiate into effector cells
➢Several factors contribute to this difference: memory cells are more sensitive to
infection, more easily activated, and more abundant than naive lymphocytes specific for
the same pathogen
➢Memory B cells have also undergone isotype switching and affinity maturation and so
will produce more effective antibodies than IgM made at the beginning of the primary
infection with the pathogen
Vaccination Against A Pathogen Can Generate
Immunological Memory That Persists For Life
➢The goal of vaccination is to immunize people with a benign form of a
pathogen and induce immunological memory
➢Any infection with the real pathogen will meet a secondary immune
response that terminates the infection before it causes disease
➢Smallpox virus was once an effective killer of humankind: from 1850 to
1979
➢About 1 billion people died from smallpox
➢Worldwide vaccination programs progressively reduced the spread of the
virus to the point at which in 1972 mass vaccination was discontinued in the
United States and in 1979 the smallpox virus was eradicated worldwide
Pathogen–Specific Memory B Cells Are More Abundant And
Make Better Antibodies Than Do Naive B Cells
➢In primary infection, proliferation and differentiation of antigen-specific
naive B cells produces large numbers of antibody – secreting plasma cells
➢A smaller number of memory B cells to deal with future infections
➢The first antibodies to be made in the primary response are low – affinity
IgM
➢As the response proceeds, somatic hypermutation, affinity maturation, and
isotype switching give rise to high-affinity IgG, IgA, and IgE
➢Memory B cells are derived from the clones of B cells making the highest-
affinity antibodies
➢On a second infection, 10-100 times more pathogen-specific B cells
respond than did naive B cells in the primary response
Immunodeficiency
• Cause for Immunodeficiency:
Human Immune system:
❖Very specific
❖Dependent on memory of cells and
lymphocytes that recognise foreign antigen
and infected cells respectively.
• Any alterations in these functions
Immunodeficiency.
Classification
•Most are genetically
determined
•Less common
•May arise as complications
of cancers, infestations,
malnutrition, or side effects
of immunosuppression,
Irradiation and
chemotherapy.
•More common
Primary
Immunodeficiency
Secondary
Immunodeficiency
Primary Immunodeficiency
• Most important feature:
• High Incidence in Males: Why ?
• 6 X-linked ID’s have been
described:
5 - Affect
Lymphocytes
1- Affect
Phagocyte
Severe Combined
Immunodeficiency(SCID)
• Synonyms: Glanzzman-Rinker syndrome,
Bubble Boy Disease, Thymic Alymphoplasia
• Genetic disorder characterised by absence of
T-lymphocytes.
• Impairment of both cellular & humoral
response
• Specific defects in antigen presentation &
functional immune molecules.
SCID-Types
• Main Types:
➢Autosomal recessive (-ve T & B cells)
➢X-linked recessive(+ve B cells)
• Other important types:
➢Nezelof Syndrome
➢SCID associated with ADA & PNP deficiency.
Features of SCID
• Absent tonsils
• Small or absent lymph nodes
• Absent thymic shadow
• Lymphopenias
• Decreased Number of T cells
• Severe agammaglobulinemia (Swiss type of
agammaglobulinemia)
• No IG’s usually present
Bruton’s X-linked Agammaglobuinemia
• Primarily B-cell defect
• Boys-more affected
• Severe reduction in γ-globulins
• IG’s, circulating and marrow B-cells.
• Probable cause: Molecular defect at
Xq22.Mutation of bruton tyrosine kinase.
• Therapy: IV IG’s.
DiGeorge’s syndrome
• Also called thymic hypoplasia
• Congenital disorder
• Abnormalities in structure derived from 3rd
and 4th pharyngeal pouches
• Predominantly T cell defect
• Charactersitics: Neonatal tetany(absence of
parathyroid)
• Therapy: Thymic transplants
Ataxia-telangiectasia
• Autosomal recessive
• Incidence: 25:10,00,000
• Characteristics: Progressive cerebellar ataxia,
ocular and cutaneous telangiectasias, severe
sino-pulmonary infections, progeric changes,
sclerodermoid changes
• Thymus: fetal-like histological pattern.
• Translocation between 14 and 7
Wiskott-Aldrich Syndrome
• X-linked condition
• Incidence: 4:10,00,000
• Severe eczema, recurrent infections, Bloody
diarrhea, chronic otitis
• T cells appear bald :?
• Platelets: Decreased in number, small
• Failure to recognise polysaccharide antigens.
• Defect: Failure in expression of sialophorin.
Chronic Granulomatous Disease
• Incidence:1:10,00,000
• Defect: Inability of phagocytes to produce
superoxide ineffective reduction of O2.
• Failure to express respiratory burst associated
with phagocytosis.
• Central necrosis and granulomatoid response
in lung, liver, bone , skin and lymph nodes.
• Presence of numerous pigmented
macrophages.
Chediak-Higashi Syndrome
• Rare autosomal disorder
• Abnormal large granules in leucocytes leading to:
– hypopigmentation/partial albinism
– severe immunodeficiency
– neurologic abnormalities
– mild bleeding tendencies
• Defective gene: CHS1
Leucocyte-Adhesion defect
• Autosomal recessive disorder
• Inability of phagocytic cells to adhere to
endothelial cells and migrate to infected sites
• Characteristics: delayed cord dehiscence and
scar formation, recurrent diarrhea and
respiratory symptoms, leucocytosis
• Defect in CD18 gene
• Treatment: Bone marrow transplantation
Other Primary ID’s
• Selective IgA deficiency
• Common variable Immunodeficiency
• X-linked lymphoproliferative disease
• Job’s syndrome
Complement deficiencies
• Involves 19 proteins:
11-classical, 3-alternate, 5-regulatory
• Alteration in the expression of these proteins
Autoimmune & Immunodeficiency diseases
Classical AI affecting vessels & glomeruli
Alternate Pyogenic infections
Regulatory Hereditary Angioneurotic edema
Diagnosis of Primary Immunodeficiencies
• Histopathology
• Immunohistochemistry
• Monoclonal Antibodies
• Cell separation by flow cytometry
• Insitu Hybridisation
Therapy
• Supportive therapy- antibiotics
• Replacement therapy-IV immunoglobulin
infusion, ADA-rich RBC infusions
• Definitive therapy- Fetal thymic grafts, bone
marrow transplantation
• Stem-cell therapy
• Gene therapy

Weitere ähnliche Inhalte

Was ist angesagt?

14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseases
ghalan
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
Fatima Awadh
 

Was ist angesagt? (20)

immunodeficiency
immunodeficiencyimmunodeficiency
immunodeficiency
 
Combined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCIDCombined T cells And Bcell Deficiency - SCID
Combined T cells And Bcell Deficiency - SCID
 
Secondary immunodeficiency
Secondary immunodeficiencySecondary immunodeficiency
Secondary immunodeficiency
 
Primary immunodeficiency disorders
Primary immunodeficiency disordersPrimary immunodeficiency disorders
Primary immunodeficiency disorders
 
Immunodeficiency Syndrome
Immunodeficiency SyndromeImmunodeficiency Syndrome
Immunodeficiency Syndrome
 
IMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASESIMMUNODEFICIENCY DISEASES
IMMUNODEFICIENCY DISEASES
 
14 Primary Immunodeficiency Diseases
14 Primary Immunodeficiency  Diseases14 Primary Immunodeficiency  Diseases
14 Primary Immunodeficiency Diseases
 
Immuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondaryImmuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondary
 
Immunodeficiency group 3
Immunodeficiency group 3Immunodeficiency group 3
Immunodeficiency group 3
 
Common variable immunodeficiency
Common variable immunodeficiencyCommon variable immunodeficiency
Common variable immunodeficiency
 
Immunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquiredImmunodeficiency disorders: inherited & acquired
Immunodeficiency disorders: inherited & acquired
 
Immunodeficiency disorders
Immunodeficiency disorders Immunodeficiency disorders
Immunodeficiency disorders
 
Aids an other immunodeficiencies.....
Aids an other immunodeficiencies.....Aids an other immunodeficiencies.....
Aids an other immunodeficiencies.....
 
Immunodeficiency Disorder
Immunodeficiency DisorderImmunodeficiency Disorder
Immunodeficiency Disorder
 
Immune deficiencies in children: an Overview
Immune deficiencies in children: an OverviewImmune deficiencies in children: an Overview
Immune deficiencies in children: an Overview
 
Immune response to hiv infection
Immune response to hiv infectionImmune response to hiv infection
Immune response to hiv infection
 
Approach to primary immunodeficiency
Approach to primary immunodeficiency Approach to primary immunodeficiency
Approach to primary immunodeficiency
 
Primary immunodeficiencies
Primary immunodeficienciesPrimary immunodeficiencies
Primary immunodeficiencies
 
Seminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndromeSeminar primary immunodeficiency syndrome
Seminar primary immunodeficiency syndrome
 
Diagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderDiagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorder
 

Ähnlich wie Primary immune dificiency

Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
GifteeJRoumi
 
Lecture-3 Immunopathology. Adaptation.pptx
Lecture-3 Immunopathology. Adaptation.pptxLecture-3 Immunopathology. Adaptation.pptx
Lecture-3 Immunopathology. Adaptation.pptx
eakbarli66
 
كيمياء.pptx. by ali rasool title the immune
كيمياء.pptx. by ali rasool title the immuneكيمياء.pptx. by ali rasool title the immune
كيمياء.pptx. by ali rasool title the immune
ssuser06f49d
 
infectiousdiseasesch8-190920170149.pptx
infectiousdiseasesch8-190920170149.pptxinfectiousdiseasesch8-190920170149.pptx
infectiousdiseasesch8-190920170149.pptx
Fraishu
 
Immunological Diseases
Immunological DiseasesImmunological Diseases
Immunological Diseases
Navid J. Ayon
 

Ähnlich wie Primary immune dificiency (20)

NCM 109 NURSING CHILD WITH IMMUNO DISORO
NCM 109 NURSING CHILD WITH IMMUNO DISORONCM 109 NURSING CHILD WITH IMMUNO DISORO
NCM 109 NURSING CHILD WITH IMMUNO DISORO
 
Immunology in ent
Immunology in entImmunology in ent
Immunology in ent
 
Secondary immune response
Secondary immune responseSecondary immune response
Secondary immune response
 
Basic Principles of Hypersensitivity Reactions
Basic Principles of Hypersensitivity ReactionsBasic Principles of Hypersensitivity Reactions
Basic Principles of Hypersensitivity Reactions
 
Immunology 1, 2, 3
Immunology 1, 2, 3Immunology 1, 2, 3
Immunology 1, 2, 3
 
Immunity
ImmunityImmunity
Immunity
 
Immunodeficiency - SCID & LAD
Immunodeficiency - SCID & LADImmunodeficiency - SCID & LAD
Immunodeficiency - SCID & LAD
 
Immunodeficiency .
Immunodeficiency .   Immunodeficiency .
Immunodeficiency .
 
Lecture 12 immunopathology
Lecture 12 immunopathologyLecture 12 immunopathology
Lecture 12 immunopathology
 
Vaccination in CKD patients
Vaccination in CKD patients Vaccination in CKD patients
Vaccination in CKD patients
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
 
Lecture-3 Immunopathology. Adaptation.pptx
Lecture-3 Immunopathology. Adaptation.pptxLecture-3 Immunopathology. Adaptation.pptx
Lecture-3 Immunopathology. Adaptation.pptx
 
UNIT III.pptx
UNIT III.pptxUNIT III.pptx
UNIT III.pptx
 
Immunology Lecture day 1 ADDU section D
Immunology Lecture day 1 ADDU section DImmunology Lecture day 1 ADDU section D
Immunology Lecture day 1 ADDU section D
 
Tropical Diseases.pptx
Tropical Diseases.pptxTropical Diseases.pptx
Tropical Diseases.pptx
 
كيمياء.pptx. by ali rasool title the immune
كيمياء.pptx. by ali rasool title the immuneكيمياء.pptx. by ali rasool title the immune
كيمياء.pptx. by ali rasool title the immune
 
infectiousdiseasesch8-190920170149.pptx
infectiousdiseasesch8-190920170149.pptxinfectiousdiseasesch8-190920170149.pptx
infectiousdiseasesch8-190920170149.pptx
 
7. immunodeficiency syndromes
7. immunodeficiency syndromes7. immunodeficiency syndromes
7. immunodeficiency syndromes
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Immunological Diseases
Immunological DiseasesImmunological Diseases
Immunological Diseases
 

Kürzlich hochgeladen

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Kürzlich hochgeladen (20)

General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 

Primary immune dificiency

  • 1. Introduction ➢A secondary immune response is a response to an illness that has occurred for the second time ➢It activates previously generated memory cells ➢Secondary immune response is different from the primary response, both qualitatively and quantitatively ➢The log phase in secondary response is very short or negligible ➢Lag face is absent in secondary response ➢Raise of antibody concentration is about 100 to 1,000 fold higher than the primary response resulting a short log phase
  • 2.
  • 3. 1° Immune Response 1. Following the first exposure to a foreign antigen, a lag phase occurs in which no antibody is produced, but activated B cells are differentiating into plasma cells. The lag phase can be as short as 2-3 days, but often is longer, sometimes as long as weeks or months. 2. The amount of antibody produced is usually relatively low. 3. Over time, antibody level declines to the point where it may be undetectable. 4. The first antibody produced is manily IgM (although small amounts of IgG are usually also produced). 2° Immune Response 1. If a second dose of the same antigen is given days or even years later, an accelerated 2° or anamnestic immune response (IR) occurs. This lag phase is usually very short (e.g. 3 or 4 days) due to the presence of memory cells. 2. The amount of antibody produced rises to a high level. 3. Antibody level tends to remain high for longer. 4. The main type of antibody produced is IgG (although small amounts of IgM are sometimes produced).
  • 4. Immunological Memory Is Sustained By Clones Of Long Lived Memory T Cells And B Cells ➢After the level of pathogen-specific antibody made during a primary immune response has declined, immune defences relaxed and the potential for that pathogen to re- establish an infection increases ➢During a primary immune response, the clonal expansion of pathogen-specific T cells and B cells gives rise both to short lived effector cells that work to stop the infection and to long-lived memory T cells and memory B cells ➢In the secondary immune response, these memory cells are activated by antigen to proliferate and differentiate into effector cells ➢Several factors contribute to this difference: memory cells are more sensitive to infection, more easily activated, and more abundant than naive lymphocytes specific for the same pathogen ➢Memory B cells have also undergone isotype switching and affinity maturation and so will produce more effective antibodies than IgM made at the beginning of the primary infection with the pathogen
  • 5. Vaccination Against A Pathogen Can Generate Immunological Memory That Persists For Life ➢The goal of vaccination is to immunize people with a benign form of a pathogen and induce immunological memory ➢Any infection with the real pathogen will meet a secondary immune response that terminates the infection before it causes disease ➢Smallpox virus was once an effective killer of humankind: from 1850 to 1979 ➢About 1 billion people died from smallpox ➢Worldwide vaccination programs progressively reduced the spread of the virus to the point at which in 1972 mass vaccination was discontinued in the United States and in 1979 the smallpox virus was eradicated worldwide
  • 6. Pathogen–Specific Memory B Cells Are More Abundant And Make Better Antibodies Than Do Naive B Cells ➢In primary infection, proliferation and differentiation of antigen-specific naive B cells produces large numbers of antibody – secreting plasma cells ➢A smaller number of memory B cells to deal with future infections ➢The first antibodies to be made in the primary response are low – affinity IgM ➢As the response proceeds, somatic hypermutation, affinity maturation, and isotype switching give rise to high-affinity IgG, IgA, and IgE ➢Memory B cells are derived from the clones of B cells making the highest- affinity antibodies ➢On a second infection, 10-100 times more pathogen-specific B cells respond than did naive B cells in the primary response
  • 7. Immunodeficiency • Cause for Immunodeficiency: Human Immune system: ❖Very specific ❖Dependent on memory of cells and lymphocytes that recognise foreign antigen and infected cells respectively. • Any alterations in these functions Immunodeficiency.
  • 8. Classification •Most are genetically determined •Less common •May arise as complications of cancers, infestations, malnutrition, or side effects of immunosuppression, Irradiation and chemotherapy. •More common Primary Immunodeficiency Secondary Immunodeficiency
  • 9. Primary Immunodeficiency • Most important feature: • High Incidence in Males: Why ? • 6 X-linked ID’s have been described: 5 - Affect Lymphocytes 1- Affect Phagocyte
  • 10.
  • 11. Severe Combined Immunodeficiency(SCID) • Synonyms: Glanzzman-Rinker syndrome, Bubble Boy Disease, Thymic Alymphoplasia • Genetic disorder characterised by absence of T-lymphocytes. • Impairment of both cellular & humoral response • Specific defects in antigen presentation & functional immune molecules.
  • 12. SCID-Types • Main Types: ➢Autosomal recessive (-ve T & B cells) ➢X-linked recessive(+ve B cells) • Other important types: ➢Nezelof Syndrome ➢SCID associated with ADA & PNP deficiency.
  • 13. Features of SCID • Absent tonsils • Small or absent lymph nodes • Absent thymic shadow • Lymphopenias • Decreased Number of T cells • Severe agammaglobulinemia (Swiss type of agammaglobulinemia) • No IG’s usually present
  • 14. Bruton’s X-linked Agammaglobuinemia • Primarily B-cell defect • Boys-more affected • Severe reduction in γ-globulins • IG’s, circulating and marrow B-cells. • Probable cause: Molecular defect at Xq22.Mutation of bruton tyrosine kinase. • Therapy: IV IG’s.
  • 15. DiGeorge’s syndrome • Also called thymic hypoplasia • Congenital disorder • Abnormalities in structure derived from 3rd and 4th pharyngeal pouches • Predominantly T cell defect • Charactersitics: Neonatal tetany(absence of parathyroid) • Therapy: Thymic transplants
  • 16. Ataxia-telangiectasia • Autosomal recessive • Incidence: 25:10,00,000 • Characteristics: Progressive cerebellar ataxia, ocular and cutaneous telangiectasias, severe sino-pulmonary infections, progeric changes, sclerodermoid changes • Thymus: fetal-like histological pattern. • Translocation between 14 and 7
  • 17. Wiskott-Aldrich Syndrome • X-linked condition • Incidence: 4:10,00,000 • Severe eczema, recurrent infections, Bloody diarrhea, chronic otitis • T cells appear bald :? • Platelets: Decreased in number, small • Failure to recognise polysaccharide antigens. • Defect: Failure in expression of sialophorin.
  • 18. Chronic Granulomatous Disease • Incidence:1:10,00,000 • Defect: Inability of phagocytes to produce superoxide ineffective reduction of O2. • Failure to express respiratory burst associated with phagocytosis. • Central necrosis and granulomatoid response in lung, liver, bone , skin and lymph nodes. • Presence of numerous pigmented macrophages.
  • 19. Chediak-Higashi Syndrome • Rare autosomal disorder • Abnormal large granules in leucocytes leading to: – hypopigmentation/partial albinism – severe immunodeficiency – neurologic abnormalities – mild bleeding tendencies • Defective gene: CHS1
  • 20. Leucocyte-Adhesion defect • Autosomal recessive disorder • Inability of phagocytic cells to adhere to endothelial cells and migrate to infected sites • Characteristics: delayed cord dehiscence and scar formation, recurrent diarrhea and respiratory symptoms, leucocytosis • Defect in CD18 gene • Treatment: Bone marrow transplantation
  • 21. Other Primary ID’s • Selective IgA deficiency • Common variable Immunodeficiency • X-linked lymphoproliferative disease • Job’s syndrome
  • 22. Complement deficiencies • Involves 19 proteins: 11-classical, 3-alternate, 5-regulatory • Alteration in the expression of these proteins Autoimmune & Immunodeficiency diseases Classical AI affecting vessels & glomeruli Alternate Pyogenic infections Regulatory Hereditary Angioneurotic edema
  • 23. Diagnosis of Primary Immunodeficiencies • Histopathology • Immunohistochemistry • Monoclonal Antibodies • Cell separation by flow cytometry • Insitu Hybridisation
  • 24. Therapy • Supportive therapy- antibiotics • Replacement therapy-IV immunoglobulin infusion, ADA-rich RBC infusions • Definitive therapy- Fetal thymic grafts, bone marrow transplantation • Stem-cell therapy • Gene therapy